Protein | Gene expression in cancer | MAM interactors | Functions at MAM | Chemotherapeutic agents that act through mechanisms related to the MAMs | References |
---|---|---|---|---|---|
AKT | Pancreas (A, D), breast (M), prostate (A) | IP3R, PTEN, PML | Inhibition of calcium release from the ER; antiapoptotic functions | MK-2206 | |
BCL-XL | Uterus (A, M), breast (A), prostate (A), colon (A), nervous system (D, M) | BCL-2, IP3R | Induction of calcium leakage from ER; antiapoptotic functions | ABT-737 | |
BCL-2 | B cell (M), central nervous system (A, M), pancreas (D), breast (A) | BCL-XL, IP3R | Induction of calcium leakage from ER; antiapoptotic functions | ABT-737 | |
MFN-2 | Pancreas (A, D), esophagus (M, A, D), prostate (M, A, D) | PERK, MFN-1 | Facilitates calcium cross-talk between the ER and mitochondria;Interacts with PERK and regulates PERK-mediated UPR | Â | |
PML | Almost all | AKT, IP3R, PP2A | Regulates apoptosis in the ER by modulating calcium release, negative regulator of Akt | Arsenic trioxide | |
PP2A | Prostate (A), central nervous system (M), pancreas (A, D) | AKT, PML | Regulates calcium transients in cardiomyocytes | SMAPs | |
PTEN | Uterus (M), prostate (M, D), head (M, D), stomach (M), breast (A, M), pancreas (M) | AKT, IP3R, PP2A | Negative regulator of Akt, regulation of calcium release via IP3R3; proapoptotic functions | LY-2779964 | |
TP53 | Almost all | SERCA | Interacts with the C-terminal portion of the SERCA pump, increasing ER Ca2+ loading | Adriamycin | |
PERK | Breast (A) | Â | Involved in folded protein response during ER stress; physically increases contacts between mitochondria and ER | GSK2656157/GSK2606414 |